Target intelligence / Profile preview

Interleukin-15 receptor (IL-15R)

Target
IL-15R
Molecular classification
Receptor, Cytokine receptor, Type I cytokine receptor, Multi-subunit receptor
01

Overview

The **Interleukin-15 receptor (IL-15R)** is a heterotrimeric cell-surface receptor essential for the biological activity of the cytokine interleukin-15 (IL-15) and plays a critical role in the development, survival, and activation of lymphocytes, particularly NK cells and memory CD8+ T cells[1][3][4]. The receptor complex consists of three subunits: a unique, high-affinity IL-15 receptor alpha (IL-15Rα), a shared beta chain (IL-2/15Rβ, also part of the IL-2 receptor), and the common gamma chain (γc, shared by several cytokine receptors)[1][3]. The IL-15Rα subunit binds IL-15 with exceptionally high affinity, often presenting IL-15 in trans to cells expressing β and γ chains, thereby enabling potent signaling[1][3][4]. Activation of the IL-15 receptor complex leads to downstream signaling through JAK kinases and STAT proteins, as well as pathways such as PI3K/Akt and MAPK, ultimately promoting immune cell proliferation, survival, and anti-apoptotic pathways[1][6][3]. Aberrant IL-15R signaling is implicated in immune dysregulation, cancer, inflammation, and other diseases, making it a significant therapeutic target for both immune-activating and immunosuppressive strategies[3][4].

Other names
IL-15RIL-15 receptorIL15 receptorInterleukin-15 receptor complexInterleukin-15 receptor subunit alpha (IL15RA)IL2/15 receptor beta chain (IL2RB)Common gamma chain (γc, IL2RG)
02

Mechanism of action

Antagonism/blockade of cytokine signaling, Promotion of immune cell activation (via agonists), Blockade of lymphocyte proliferation and survival (via antagonists)

03

Biological functions

Immune responseLymphocyte activation and homeostasisSignal transductionCell proliferationNatural killer (NK) cell activationApoptosis regulation
04

Disease associations

CancerInflammationInfectionAutoimmune diseaseImmunodeficiency
05

Safety considerations

Cytokine release syndromeAutoimmunityLymphoproliferative disordersOff-target immune activation
06

Interacting drugs

AMG 714 (anti-IL-15 monoclonal antibody)

3 more in the full profile.

07

Biomarkers

Expression of IL-15Rα on lymphocytes, NK cells, or dendritic cellssoluble IL-15/IL-15Rα complex in serum

Beyond the preview

Go deeper on Interleukin-15 receptor (IL-15R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-15 receptor (IL-15R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call